Microneedles for drug and vaccine delivery

By Yeu‐Chun Kim, Jung-Hwan Park, Mark R. Prausnitz. Advanced Drug Delivery Reviews, 2012

1,621 citations recorded by the source corpus.

Microneedles were first conceptualized for drug delivery many decades ago, but only became the subject of significant research starting in the mid-1990’s when microfabrication technology enabled their manufacture as (i) solid microneedles for skin pretreatment to increase skin permeability, (ii) microneedles coated with drug that dissolves off in the skin, (iii) polymer microneedles that encapsulate drug and fully dissolve in the skin and (iv) hollow microneedles for drug infusion into the skin. As shown in more than 350 papers now published in the field, microneedles have been used to deliver a broad range of different low molecular weight drugs, biotherapeutics and vaccines, including published human studies with a number of small-molecule and protein drugs and vaccines. Influenza vaccination using a hollow microneedle is in widespread clinical use and a number of solid microneedle products are sold for cosmetic purposes. In addition to applications in the skin, microneedles have also been adapted for delivery of bioactives into the eye and into cells. Successful application of microneedles depends on device function that facilitates microneedle insertion and possible infusion into skin, skin recovery after microneedle removal, and drug stability during manufacturing, storage and delivery, and on patient outcomes, including lack of pain, skin irritation and skin infection, in addition to drug efficacy and safety. Building off a strong technology base and multiple demonstrations of successful drug delivery, microneedles are poised to advance further into clinical practice to enable better pharmaceutical therapies, vaccination and other applications.

Subfields: Immunology, Pharmaceutical Science

View Paper: https://www.semanticscholar.org/paper/23a2fcfaca2e3e5747b0f96aec6d7552f0c13a4d

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Immunology

1. Ahlam Zaid Alkilani
2. R. Donnelly
3. Maelíosa T. C. McCrudden

In Pharmaceutical Science

1. Ahlam Zaid Alkilani
2. Ali Khademhosseini
3. R. Donnelly
4. Maelíosa T. C. McCrudden

Citations in the corpus

• Drug Delivery Systems and Materials for Wound Healing Applications (2018, positive): “These microneedles can be categorized into four groups (Figure 6a): i) solid microneedles disrupting the epidermis barrier and enabling the penetration of topically administered drugs [202], ii) microneedles coated with drugs that can penetrate the tissue and deliver their payload in there [203], ii”
• Transdermal Drug Delivery: Innovative Pharmaceutical Developments Based on Disruption of the Barrier Properties of the stratum corneum (2015, methodology): “Generally, there are four strategies of TDD using MN (Figure 15) [22,123].”